Generic Drugs Current Affairs - 2019

Category Wise PDF Compilations available at This Link

WHO launches plan for cheaper TB drugs

World Health Organization (WHO) has invited pharmaceutical companies around the world to submit proposals to manufacture affordable versions of newer medicines for treatment of drug resistant tuberculosis (DR-TB). It has now requested drug makers to submit Expression of Interest (EoI) for Bedaquiline and Delaminid, two new-generation drugs, recommended for DR-TB. The aim of this proposal Read More…

Month:  Categories: International

Tags:

WHO settles India, EU medicine dispute issue

The World Health Organisation (WHO) has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality. This decision was taken by a WHO’s technical working group on draft working definitions of substandard/spurious /falsely-labelled/falsified/counterfeit (SSFFC) medical products. It settles longstanding India, EU medicine dispute and battle about labelling of drugs. It is considered Read More…

Month:  Categories: International

Tags:

Delink drug prices from R&D costs: UN

The United Nations High-Level Panel on Access to Medicines has called for delinking drug prices from research and development (R&D) costs. The report submitted by panel calls for human rights to be placed over intellectual property laws of pharmaceutical companies and incoherence between them should be narrowed. Key Recommendations All countries must freely be able Read More…

Month:  Categories: International

Tags:

US FDA hikes fee for generic drug approvals

United state Food and Drugs Administration (USFDA) has hiked its fees by 30 percent for new generic drug applications. Earlier the fee for Abbreviated New Drug Applications (ANDAs) was 58,730 dollars and now has risen by 30 per cent to 76,030 US dollars. This fee is applicable from 1 October 2015. This move will hit Indian Read More…

Month:  Categories: Business, Economy & Banking

Tags:

Teva to buy Allergan generic drug business for USD 40.5 billion

Israel’s largest drug maker Teva Pharmaceutical agreed to buy generic drugs business of Allergan Plc for USD 40.5 billion. According to the agreement Teva will make cash payment of USD 33.75 billion and USD 6.75 billion of its stock for Allergan. This is the largest acquisition done by any company in Israel’s history. The acquisition will consolidate Teva’s Read More…

Month:  Categories: Business, Economy & Banking

Tags:

Monthly Current Affairs Compilations are also available in GKToday's Academy App for Android Mobiles. Download Now